[HTML][HTML] Treatment biomarkers for ADHD: Taking stock and moving forward

G Michelini, LJ Norman, P Shaw, SK Loo - Translational psychiatry, 2022 - nature.com
The development of treatment biomarkers for psychiatric disorders has been challenging,
particularly for heterogeneous neurodevelopmental conditions such as attention …

[HTML][HTML] Genetic architecture of ADHD and overlap with other psychiatric disorders and cognition-related phenotypes

M Ribasés, M Mitjans, CA Hartman, MS Artigas… - Neuroscience & …, 2023 - Elsevier
Attention-deficit/hyperactivity disorder (ADHD) co-occurs with many other psychiatric
disorders and traits. In this review, we summarize and interpret the existing literature on the …

Incidence, prevalence, and global burden of ADHD from 1990 to 2019 across 204 countries: data, with critical re-analysis, from the Global Burden of Disease study

S Cortese, M Song, LC Farhat, DK Yon, SW Lee… - Molecular …, 2023 - nature.com
Data on incidence, prevalence and burden of ADHD are crucial for clinicians, patients, and
stakeholders. We present the incidence, prevalence, and burden of ADHD globally and …

[HTML][HTML] S2k-Leitlinie zur fachärztlichen Diagnostik und Therapie von Asthma 2023

M Lommatzsch, CP Criée, CCM de Jong… - …, 2023 - thieme-connect.com
Das Management von Asthma hat sich in den letzten Jahrzehnten fundamental gewandelt.
Die vorliegende Leitlinie zur Diagnostik und Therapie von Asthma wurde für pneumologisch …

The diagnosis and treatment of attention-deficit hyperactivity disorder (ADHD) in older adults

M Dobrosavljevic, H Larsson… - Expert Review of …, 2023 - Taylor & Francis
Introduction There is a striking knowledge gap on ADHD in older adults, and the diagnosis
as well as treatment for ADHD in this age group. Areas covered The authors first review the …

[HTML][HTML] The role of insulin/IGF1 signalling in neurodevelopmental and neuropsychiatric disorders–evidence from human neuronal cell models

JM Réthelyi, K Vincze, D Schall, J Glennon… - … & Biobehavioral Reviews, 2023 - Elsevier
Insulin and insulin-like growth factor 1 (IGF1) signalling play a central role in the
development and maintenance of neurons in the brain, and in humans neurodevelopmental …

[HTML][HTML] The role of ADHD genetic risk in mid-to-late life somatic health conditions

M Garcia-Argibay, E du Rietz, Y Lu, J Martin… - Translational …, 2022 - nature.com
Growing evidence suggests that ADHD, an early onset neurodevelopmental disorder, is
associated with poor somatic health in adulthood. However, the mechanisms underlying …

ADHD medication discontinuation and persistence across the lifespan: a retrospective observational study using population-based databases

I Brikell, H Yao, L Li, A Astrup, L Gao, MB Gillies… - The Lancet …, 2024 - thelancet.com
Background Although often intended for long-term treatment, discontinuation of medication
for ADHD is common. However, cross-national estimates of discontinuation are missing due …

[HTML][HTML] The prevalence and risk factors for cognitive impairment in obesity and NAFLD

CW Wernberg, LL Grønkjær, BG Jacobsen… - Hepatology …, 2023 - journals.lww.com
Background: Severe obesity may be accompanied by cognitive dysfunction and NAFLD, but
the associations remain unclear. We describe the prevalence and features of cognitive …

[HTML][HTML] Dopamine in the regulation of glucose homeostasis, pathogenesis of type 2 diabetes, and chronic conditions of impaired dopamine activity/metabolism …

G Lisco, A De Tullio, M Iovino, O Disoteo… - Biomedicines, 2023 - mdpi.com
Dopamine regulates several functions, such as voluntary movements, spatial memory,
motivation, sleep, arousal, feeding, immune function, maternal behaviors, and lactation …